Clovis Oncology, Inc.

Historical 13F Holders

Symbol
CLVSQ
CUSIP
189464100
All holders as of
Q3 2023
Type
Equity
Class
COM
Reported Value, Excluding Options
Total Filings
Period Filings Shares, Excl. Options Value, Excl. Options
2023 Q3 1 229 $11.0 k
2023 Q1 2 36.8 k $520 k
2022 Q4 15 401 k $525 k
2022 Q3 116 35.6 M $42.9 M
2022 Q2 134 42.1 M $75.8 M
2022 Q1 174 55.8 M $144 M
2021 Q4 178 67.0 M $202 M
2021 Q3 178 61.7 M $292 M
2021 Q2 184 55.4 M $338 M
2021 Q1 185 50.0 M $371 M
2020 Q4 197 55.8 M $289 M
2020 Q3 204 51.1 M $319 M
2020 Q2 193 46.2 M $330 M
2020 Q1 197 34.0 M $224 M
2019 Q4 208 35.0 M $365 M
2019 Q3 200 51.0 M $201 M
2019 Q2 214 51.8 M $770 M
2019 Q1 232 49.9 M $1.24 B
2018 Q4 206 54.0 M $970 M
2018 Q3 237 56.5 M $1.66 B
2018 Q2 249 55.1 M $2.50 B
2018 Q1 261 50.4 M $2.66 B
2017 Q4 284 51.4 M $3.50 B
2017 Q3 299 50.5 M $4.16 B
2017 Q2 320 48.9 M $4.57 B
2017 Q1 267 44.1 M $2.81 B
2016 Q4 200 38.0 M $1.69 B
2016 Q3 200 39.5 M $1.42 B
2016 Q2 143 38.2 M $524 M
2016 Q1 158 37.6 M $722 M
2015 Q4 193 41.3 M $1.45 B
2015 Q3 212 35.9 M $3.35 B
2015 Q2 194 32.3 M $2.84 B
2015 Q1 168 32.5 M $2.41 B
2014 Q4 155 33.4 M $1.87 B
2014 Q3 153 28.9 M $1.31 B
2014 Q2 154 28.3 M $1.17 B
2014 Q1 150 27.2 M $1.89 B